tetrabenazine has been researched along with florbetapir f 18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, CH; Arora, A; Galasko, D; Joshi, AD; Liebsack, C; Lu, M; Mintun, MA; Pontecorvo, MJ; Sabbagh, MN; Shill, HA; Siderowf, A; Skovronsky, DM | 1 |
| Adler, CH; Beach, TG; Belden, CM; Driver-Dunckley, E; Dugger, BN; Gupta, HV; Joshi, AD; Liebsack, C; Mehta, SH; Mintun, MA; Pontecorvo, MJ; Sabbagh, MN; Serrano, GE; Shill, HA; Siderowf, A; Sue, LI | 1 |
2 other study(ies) available for tetrabenazine and florbetapir f 18
| Article | Year |
|---|---|
PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Dopamine; Drug Combinations; Ethylene Glycols; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2014 |
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Dopamine; Ethylene Glycols; Fatal Outcome; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2021 |